Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
10% Owner
- 2024
- Oct 17, 2024
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Shanghai Fosun Pharmaceutical (Group) Co., Ltd. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. - $2.61M in NATR purchases and sales in the last 12 months
- Daniel C. Norman - $759K in NATR purchases and sales in the last 12 months
- Bryant J. Yates - $751K in NATR purchases and sales in the last 12 months
- Nathan G. Brower - $341K in NATR purchases and sales in the last 12 months
- Jonathan David Lanoy - $201K in NATR purchases and sales in the last 12 months
- Kevin R. Herbert - $41K in NATR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Shanghai Fosun Pharmaceutical (Group) Co., Ltd.?
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a corporate entity, tracked as 10% Owner of NATURES SUNSHINE PRODUCTS INC (NATR). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Shanghai Fosun Pharmaceutical (Group) Co., Ltd. last file a Form 4?
The most recent primary Form 4 on record is dated 17 October 2024, one of 2 filings going back to 2024.
Has Shanghai Fosun Pharmaceutical (Group) Co., Ltd. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($175K) across all tracked filings.
